Search Within

Weinberg Fellows

Formats
  1. Meeting Abstract (1374)
  2. Journal Article (1150)
  3. Review (130)
  4. Editorial (65)
  5. Research Letter (36)
  6. Book Section (25)
  7. Correspondence (24)
  8. Guidelines (12)
  9. Conference Paper (2)
  10. Miscellaneous (1)
Groups
  1. Hematology-Oncology Fellows (2746)
  2. Department of Medicine (2703)
  3. Solid Tumor Oncology Division (2002)
  4. Hematologic Malignancies, Division of (1330)
  5. GSK Faculty (1228)
  6. Department of Pathology and Laboratory Medicine (982)

More Groups

People
  1. Michael Berger (218)
  2. Marc Ladanyi (198)
  3. Pedram Razavi (184)
  4. Michael Offin (176)
  5. Sergio Giralt (171)
  6. Maria Carlo (168)

More People

Years
  1. 2025 (206)
  2. 2024 (414)
  3. 2023 (330)
  4. 2022 (377)
  5. 2021 (339)
  6. 2020 (323)

More Years

Publications
  1. Journal of Clinical Oncology (568)
  2. Blood (299)
  3. Annals of Oncology (107)
  4. Clinical Cancer Research (102)
  5. Journal of Thoracic Oncology (96)
  6. Cancer Research (87)

More Publications

Publishers
  1. American Society of Clinical Oncology (643)
  2. Elsevier Inc. (343)
  3. American Society of Hematology (339)
  4. American Association for Cancer Research (239)
  5. Nature Publishing Group (201)
  6. Oxford University Press (157)

More Publishers

Results (2819)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combinatorial cancer immunotherapies
    Journal Article

    Hellmann, M. D.; Friedman, C. F.; Wolchok, J. D.
    Advances in Immunology (2016)

    Fulltext@MSK | Save
  • How the Affordable Care Act has affected cancer care in the United States: Has value for cancer patients improved?
    Journal Article

    Schleicher, S. M.; Wood, N. M.; Lee, S.; Feeley, T. W.
    Oncology (Norwalk) (2016)

    Fulltext@MSK | Save
  • Molecular therapy for acute myeloid leukaemia
    Journal Article

    Coombs, C. C.; Tallman, M. S.; Levine, R. L.
    Nature Reviews Clinical Oncology (2016)

    Fulltext@MSK | Save
  • The future of cancer treatment: Immunomodulation, CARs and combination immunotherapy
    Journal Article

    Khalil, D. N.; Smith, E. L.; Brentjens, R. J.; Wolchok, J. D.
    Nature Reviews Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cells
    Journal Article

    Guryanova, O. A.; Lieu, Y. K.; Garrett-Bakelman, F. E.; Spitzer, B.; Glass, J. L.; Shank, K.; Martinez, A. B. V.; Rivera, S. A.; Durham, B. H.; Rapaport, F.; more...
    Leukemia (2016)

    Fulltext@MSK | Save
  • Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice
    Journal Article

    Shono, Y.; Docampo, M. D.; Peled, J. U.; Perobelli, S. M.; Velardi, E.; Tsai, J. J.; Slingerland, A. E.; Smith, O. M.; Young, L. F.; Gupta, J.; more...
    Science Translational Medicine (2016)

    Fulltext@MSK | Save
  • The role of neoadjuvant trials in drug development for solid tumors
    Journal Article

    Funt, S. A.; Chapman, P. B.
    Clinical Cancer Research (2016)

    Fulltext@MSK | Save
  • Myeloablative conditioning and CD34+ selection results in higher chronic-GVHD free/relapse free-survival compared to reduced-intensity conditioning and unmodified graft in patients with AML and MDS > 50 years receiving HLA-matched allogeneic HCT
    Meeting Abstract

    Barba, P.; Martino, R.; Zhou, Q.; Cho, C.; Castro-Malaspina, H.; Devlin, S.; Esquirol, A.; Giralt, S.; Jakubowski, A.; Lopez-Corral, L.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Long-term prognosis of one-year survivors of CD34-selected allogeneic hematopoietic stem cell transplantation: A landmark analysis
    Meeting Abstract

    Cho, C.; Hsu, M.; Avecilla, S.; Barba, P.; Barker, J.; Castro-Malaspina, H.; Devlin, S.; Giralt, S.; Jakubowski, A.; Koehne, G.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Sirolimus, tacrolimus and low-dose methotrexate as GVHD prophylaxis is safe and associated with promising results in patients receiving reduced-toxicity allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Avila, A. M.; Barba, P.; Cho, C.; Devlin, S.; Ceberio, I.; Ponce, D.; Maloy, M.; Perales, M. A.
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save